跳至主要内容
临床试验/ITMCTR2022000052
ITMCTR2022000052招募中1 期

Study of the early prediction and evaluation of the effect of Jianpi Bushen Decoction on Avascular Necrosis of the Femoral Head at ARCO stages 2 and 3 based on CT radiomics and deep learning

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Prognosis study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • Patients with avascular necrosis of the femoral head treated with Jianpi Bushen Decoction with the syndrome of phlegm and blood stasis blocking collaterals, and the age is greater than or equal to 18 years old. All patients signed informed consent and voluntarily participated in this trial.

排除标准

  • ?Age less than 18 years old;
  • ?Rheumatic immune diseases, such as connective tissue disease, ankylosing spondylitis, etc.;
  • ?Severe hip osteoarthritis on the image;
  • ?History of hip trauma;
  • ?History of hip surgery or invasive examination and treatment;
  • ?Incomplete clinical data, no Harris score of hip joint;
  • ?Treatment time is less than 6 months;
  • ?There is nofollow-up image data, or the image data is incomplete and the image quality is poor.

研究者

相似试验